Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

IJPRT. 2020; 10(2): 25-33


HESPERIDIN AND DIOSMIN - A NOVEL DRUGS

JAYDEEP ROY, MOHAMMAD AZAMTHULLA, DHRUBOJYOTHI MUKKERJEE.




Abstract

Hesperidin, famously known as Vitamin P and Diosmin are the popular, abundant and inexpensive products obtained from citrus agronomy. With no signs of toxicity, these flavonoids are largely consumed as a dietary supplement and have a long history of medication. In various studies, conducted on Hesperidin & Diosmin have reported a number of protective potentials such as neuroprotective, cardio protective, hepato protective, anti-inflammatory, antioxidant, lipid lowering, and insulin-sensitizing properties. Despite their enormous remedial potential, the poor aqueous solubility and minimal bioavailability are some major curbs that restrict the utilization of Hesperidin and Diosmin in medical perception. Though, future of medicine belongs to synthesis and usage of nano-dimensioned materials by means of nanotechnology which has been revolutionising the delivery of different constituents with much more precision oriented delivery to the target.
This review highlights the in vivo and clinical studies to elucidate the therapeutic and pharmacological properties of Hesperidin & Diosmin that have been reported since 2015, also displays the gaps in our knowledge about both the compounds and the growing influence of nanotechnology to overcome the characteristic limitations which deserves more exploration.

Key words: Flavonoids, Diosmin, Hesperidin, Nano formulation






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.